*SANOFI COMPLETES ACQUISITION OF BLUEPRINT MEDICINES
*TENDER OFFER FOR BLUEPRINT SHARES EXPIRED JULY 17, 2025
*ACCEPTED PAYMENT FOR ALL VALIDLY TENDERED SHARES
*ACQUISITION INCLUDES AYVAKIT APPROVED IN US AND EU
*BLUEPRINT STOCK WILL CEASE TRADING ON NASDAQ
((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 18-JUL-202505:00:00.183 GMT